To strengthen the Meth-induced AD-like changes, our previous works showed that Meth exposure greatly upregulated amyloid beta (Aβ) and hyperphosphorylated tau (p-tau) [13–15], which are two principle biomarkers for AD-like pathological changes. The gene discussed is MAPT; the disease is Alzheimer disease.